China Is Starting to Pull Ahead of US in AI Race

China now leads the US in AI research publications, citations, and AI patent grants, with 2024 patent grants at over 74% globally versus 12% for the US and 3% for the EU. Stanford’s 2026 report says China has nearly erased the US lead in model performance, with the top US model ahead by only 2.7% as of March 2026. The US still leads in private AI investment at $258.9 billion versus China’s $12.4 billion, but the piece frames the gap as narrowing sharply in a strategic AI race.

Analysis

The market implication is not that one country “wins AI” in a linear way, but that the cost curve of model capability is becoming less differentiated while the industrialization layer is becoming the real battleground. If China is over-indexing on patents, robotics, and deployment density, the edge migrates from frontier model IP toward manufacturing automation, industrial software, sensors, and power infrastructure — areas where revenue converts faster and is harder to benchmark from model leaderboards alone. That favors suppliers to automation and capital equipment, while pure-play AI software names face a higher bar to sustain premium multiples unless they own distribution or proprietary workflow data.

The second-order effect is on global capex allocation. A huge US private spend number signals that the US ecosystem is still funding capacity, but if performance gaps are now single-digit and oscillating, the marginal dollar of AI investment is at risk of lower incremental return on capital. That is bearish for late-stage, high-multiple AI infra and application names that depend on perpetual re-acceleration in spend; it is more constructive for picks-and-shovels beneficiaries with pricing power and long replacement cycles, especially in power, grid, cooling, and industrial automation.

The geopolitical risk is that both sides intensify export controls and data/localization barriers, which fragments the stack and creates duplicated supply chains. In the near term that can support domestic winners in each market, but over 12-24 months it raises costs and compresses cross-border monetization, especially for semiconductor equipment, cloud, and enterprise software vendors with China exposure. A meaningful reversal would require either a policy détente or a visible Chinese slowdown in private capital formation; absent that, the trend is more likely to shift capital toward industrial AI deployment rather than frontier model speculation.

Contrarian read: the consensus may be overestimating how much patent counts translate into economic profit and underestimating the US advantage in monetization, ecosystem depth, and access to capital. The real risk for China is not model quality, but whether domestic demand and margins can absorb the deployment pace without flooding the market with low-ROI automation projects. For investors, that means fading simplistic “China AI beats US AI” narratives and instead owning the enablers of scale where utilization, not headline innovation, determines returns.

Key Decisions for Investors

• Long ABB / HON / IR for 6-12 months versus a basket of high-multiple AI software names (or QQQ if single-name shorting is impractical): thesis is industrial AI adoption monetizes faster than frontier-model hype; risk/reward improves if capex rotates from model training into factory automation.
• Long VRT or ETN on any pullback over the next 1-3 months: higher AI deployment intensity should keep demand for power, cooling, and electrical infrastructure elevated; use tight stops because these names are already crowded.
• Pair trade: long semiconductor equipment with less China revenue concentration, short the most China-exposed analog/global industrial tech names for 3-6 months: tariff/export-control fragmentation should widen dispersion and punish names dependent on cross-border demand.
• Buy 6-12 month put spreads on a basket of unprofitable AI application/software names: if incremental AI spend is showing diminishing returns, multiple compression can hit faster than revenue downgrades.
• For contrarian exposure to China AI scale-up, prefer select robotics/automation beneficiaries over broad China tech beta; size small and hedge FX/geopolitical risk, since policy support can help shares even if economic ROI remains weak.